A novel prediction model for the completion of six cycles of radium-223 treatment and survival in patients with metastatic castration-resistant prostate cancer

PURPOSE: We evaluated the predictive factors for completion of all six cycles of radium-223 (Ra-223) treatment in patients with metastatic castration-resistant prostate cancer (mCRPC). We also developed a novel prediction model for Ra-223 treatment completion using these predictors. METHODS: We retr...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyoshi, Yasuhide, Tsutsumi, Sohgo, Yasui, Masato, Kawahara, Takashi, Uemura, Ko-ichi, Hayashi, Naruhiko, Nozawa, Masahiro, Yoshimura, Kazuhiro, Uemura, Hiroji, Uemura, Hirotsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510910/
https://www.ncbi.nlm.nih.gov/pubmed/33644830
http://dx.doi.org/10.1007/s00345-021-03639-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510910/
https://www.ncbi.nlm.nih.gov/pubmed/33644830
http://dx.doi.org/10.1007/s00345-021-03639-z

Ejemplares similares